EichorEICHOR
Location: Sarajevo Synced from ClinicalTrials.gov · August 09, 2026

Clinical studies recruiting near Sarajevo

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

The C-MIC-II Follow-Up Study
NA · University Clinical Center of Sarajevo · Berlin Heals GmbH · NCT05189860A Study to Evaluate Pharmacokinetics (PK) and Safety of Subcutaneous (SC) Ublituximab Administered at Various Injection
Phase 2 · TG Therapeutics Investigational Trial Site · TG Therapeutics, Inc. · NCT07503873A Study to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB12 (Proposed Pembrolizumab Biosimilar) to
Phase 3 · Site 103001 · mAbxience Research S.L. · NCT06687369SCAD : a Registry of Spontaneous Coronary Artery Dissection
Phase N/A · Clinical Center University of Sarajevo · European Society of Cardiology · NCT06601270A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Pre
Phase 3 · GC2202 Study Site 701 · Grifols Therapeutics LLC · NCT05645107Therapeutic Equivalence of CHF5993 pMDI 100/6/12.5 µg HFA-152a in Subjects With Mild to Moderate Asthma
Phase 2 · Dr. Abdulah Nakas General Hospital_Site n. 070007 · Chiesi Farmaceutici S.p.A. · NCT07301736A Study to Evaluate the Safety and Activity of SAR448501/DR-0201 in Patients With Autoimmune Rheumatic Diseases
Phase 1 · Investigational Site Number : 001-401 · Sanofi · NCT06647069A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Phase 2 · Site 483 · Spyre Therapeutics, Inc. · NCT07012395Apixaban Safety and Therapy Adherence in Patients With Atrial Fibrillation
Phase N/A · Clinic for diseases of the heart, blood vessels and rheumati · Bosnalijek D.D · NCT07458191A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer
Phase 1 · Site 1002 · K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis P · NCT04516447Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis
Phase 3 · 842 University Clinical Centre Sarajevo · Can-Fite BioPharma · NCT05201404A Clinical Trial Evaluating the Safety and Efficacy of AP1189 Versus Placebo as an add-on to Standard of Care in Partici
Phase 2 · University Clinical Centre Sarajevo, Clinic for Infectious D · SynAct Pharma Aps · NCT07633288Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Phase 2 · Site Number - 5403 · Immunovant Sciences GmbH · NCT07032662A Study of Aumolertinib in European Participants With Non-Small Cell Lung Cancer
Phase 1 · Clinical Center University of Sarajevo, Bolnicka 25 · Jiangsu Hansoh Pharmaceutical Co., Ltd. · NCT07130916
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.